These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 769940)

  • 1. Impairment of rosette-forming T lymphocytes in patients with primary intracranial tumors.
    Brooks WH; Roszman TL; Rogers AS
    Cancer; 1976 Apr; 37(4):1869-73. PubMed ID: 769940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlations among cutaneous reactivity to DNCB, PHA-induced lymphocyte blastogenesis and peripheral blood E rosettes.
    Catalona WJ; Tarpley JL; Potvin C; Chretien PB
    Clin Exp Immunol; 1975 Feb; 19(2):327-33. PubMed ID: 1082390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased autologous rosette-forming T lymphocytes in alcoholic cirrhosis: absence of correlation with other T cell markers and with delayed cutaneous hypersensitivity.
    Lang JM; Ruscher H; Hasselmann JP; Grandjean P; Bigel P; Mayer S
    Int Arch Allergy Appl Immunol; 1980; 61(3):337-43. PubMed ID: 6965492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T rosettes in alcoholic cirrhosis of the liver.
    Berenyi MR; Straus B; Avila L
    JAMA; 1975 Apr; 232(1):44-6. PubMed ID: 1090766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
    Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
    No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosette-forming T lymphocytes and cell-mediated immunity in malnutrition.
    Chandra RK
    Br Med J; 1974 Sep; 3(5931):608-9. PubMed ID: 4214461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
    Brooks WH; Netsky MG; Normansell DE; Horwitz DA
    J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity in patients with carcinoma: correlation between clinical stage and immunocompetence.
    Kopersztych S; Rezkallah MT; Miki SS; Naspitz CK; Mendes NF
    Cancer; 1976 Sep; 38(3):1149-54. PubMed ID: 1085193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative cell-mediated immune status of gastric cancer patients.
    Orita K; Miwa H; Fukuda H; Yumura M; Uchida Y
    Cancer; 1976 Dec; 38(6):2343-8. PubMed ID: 793709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical evaluation of lymphocyte functions in urological cancer patients.
    Elhilali MM; Paika KD; Brosman S; Fahey JL
    Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The active E rosette test: correlation with delayed cutaneous hypersensitivity.
    Felsburg PJ; Edelman R; Bilman RH
    J Immunol; 1976 Apr; 116(4):1110-4. PubMed ID: 1082906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood lymphocyte subsets in patients with primary intracranial tumours. Correlation to histological tumour type and anatomical site.
    Ullén H; Blom U; Blomgren H; von Holst H
    Acta Neurochir (Wien); 1986; 81(3-4):100-5. PubMed ID: 3489354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of human T lymphocytes to bind sheep erythrocytes and mitogenic responses of their subpopulations.
    Sasaki M; Sekizawa T; Takahashi H; Abo T; Kumagai K
    J Immunol; 1975 Dec; 115(6):1509-14. PubMed ID: 1081102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology of paediatric intracranial tumours. A preliminary report.
    Gerosa M; Amadori G; Semenzato C; Raumer R; Cisotto P; Pezzuto A; Gasparotto G; Carteri A
    Acta Neurochir (Wien); 1979; 50(1-2):49-54. PubMed ID: 316267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunological effects of thymectomy in myasthenia gravis.
    Scadding GK; Thomas HC; Havard CW
    Clin Exp Immunol; 1979 May; 36(2):205-13. PubMed ID: 314366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Humoral and cellular immunity in patients with left- and right-sided intracerebral tumors].
    Lisianyĭ NI; Markova OV; Prikhodchenko IA; Primushko LI
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (2):33-5. PubMed ID: 2787570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
    Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L
    J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319
    [No Abstract]   [Full Text] [Related]  

  • 20. The active E-rosette test: a sensitive in vitro correlate for human delayed-type hypersensitivity.
    Felsburg PJ; Edelman R
    J Immunol; 1977 Jan; (1):62-6. PubMed ID: 299750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.